KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Emergent BioSolutions (EBS) Other Non Operating Income (2016 - 2025)

Historic Other Non Operating Income for Emergent BioSolutions (EBS) over the last 17 years, with Q3 2025 value amounting to -$3.7 million.

  • Emergent BioSolutions' Other Non Operating Income fell 11689.5% to -$3.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $59.0 million, marking a year-over-year increase of 12014.93%. This contributed to the annual value of $12.5 million for FY2024, which is 4044.94% up from last year.
  • As of Q3 2025, Emergent BioSolutions' Other Non Operating Income stood at -$3.7 million, which was down 11689.5% from -$3.7 million recorded in Q2 2025.
  • Emergent BioSolutions' 5-year Other Non Operating Income high stood at $69.7 million for Q1 2025, and its period low was -$13.4 million during Q3 2022.
  • In the last 5 years, Emergent BioSolutions' Other Non Operating Income had a median value of -$2.4 million in 2021 and averaged $3.6 million.
  • Per our database at Business Quant, Emergent BioSolutions' Other Non Operating Income tumbled by 45833.33% in 2022 and then surged by 215000.0% in 2025.
  • Emergent BioSolutions' Other Non Operating Income (Quarter) stood at -$900000.0 in 2021, then soared by 844.44% to $6.7 million in 2022, then soared by 64.18% to $11.0 million in 2023, then tumbled by 130.0% to -$3.3 million in 2024, then fell by 12.12% to -$3.7 million in 2025.
  • Its Other Non Operating Income stands at -$3.7 million for Q3 2025, versus -$3.7 million for Q2 2025 and $69.7 million for Q1 2025.